Farmaceutica R Stock Price To Earnings To Growth
| RMAH Stock | 0.67 0.02 3.08% |
Farmaceutica R fundamentals help investors to digest information that contributes to Farmaceutica's financial success or failures. It also enables traders to predict the movement of Farmaceutica Stock. The fundamental analysis module provides a way to measure Farmaceutica's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Farmaceutica stock.
Farmaceutica |
Farmaceutica R Company Price To Earnings To Growth Analysis
Farmaceutica's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
Based on the latest financial disclosure, Farmaceutica R has a Price To Earnings To Growth of 0.0 times. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Price To Earnings To Growth (which currently averages 0.0) industry. This indicator is about the same for all Romania stocks average (which is currently at 0.0).
Did you try this?
Run Equity Analysis Now
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
| All Next | Launch Module |
About Farmaceutica Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Farmaceutica R's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Farmaceutica using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Farmaceutica R based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Farmaceutica
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Farmaceutica position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Farmaceutica will appreciate offsetting losses from the drop in the long position's value.Moving together with Farmaceutica Stock
The ability to find closely correlated positions to Farmaceutica could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Farmaceutica when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Farmaceutica - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Farmaceutica R to buy it.
The correlation of Farmaceutica is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Farmaceutica moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Farmaceutica R moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Farmaceutica can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Farmaceutica Stock
Farmaceutica financial ratios help investors to determine whether Farmaceutica Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Farmaceutica with respect to the benefits of owning Farmaceutica security.